65,437 trials
Sly Syndrome · MPS VII · Mucopolysaccharidosis
Primary: Percent Change From Baseline in uGAG Excretion (LC-MS/MS-DS) at Week 48 — -58.17 percent change — p=< 0.0001
Atrial Fibrillation
Primary: Number of Participants With Acute Success — 53 Participants
Uncontrolled Hypertension
Primary: Mean Change in Office Systolic Blood Pressure at 6 Months — -13.6 mmHg
Dermatologic Complications · Malignant Neoplasm · Pain
Primary: Change From Baseline to Week 4 Face Pain Score Measuring Cutaneous Discomfort — 2.0; 3.0 score on a scale — p=0.6311
Prostate Cancer
Primary: 5-Year Freedom From Progression Rate — 85.5; 83.1 percentage of participants — p=0.21
AIDS-Related Hodgkin Lymphoma · Recurrent Adult Hodgkin Lymphoma · Recurrent Follicular Lymphoma
Primary: Incidence of Dose-limiting Toxicity (DLT), Phase I Patients Only — 1; 0; 3; 0 Participants
HIV/AIDS and Infections · Sexually Transmitted Diseases · Pregnancy Prevention
Primary: Change From Baseline to 3 Months in Parent - Adolescent Sexual Risk Communication (Parental Perspective) — 0.54; 0.28 units on a scale
Lymphoma
Primary: Overall Response Rate (ORR) of Patients With Burkitt's and Burkitt-like Lymphoma/Leukemia Treated With Modified Magrath Regimen — 100; 100; 100; 100 percentage of patients
Chronic Kidney Disease
Primary: Number of Participants With Treatment-related Adverse Events — 0 Participants
Post-polypectomy Bleeding · Polypectomy · Elective Colonoscopy
Primary: Number of Patients With Delayed Post Polypectomy Bleeding — 12; 15 Participants
Mild Cognitive Impairment (MCI) · Depression
Primary: Change in Hamilton Depression Rating Scale — 17.8; 17.7; 6.0; 6.7 units on a scale
Hypoglycemia · Diabetes Mellitus · Drug-Specific Antibodies
Primary: Percentage of Participants Awakening or Returning to a Normal Status Within 30 Minutes Following Studied Drug of Administration — 95.7 percentage of participants
Constipation Predominant Irritable Bowel Syndrome
Primary: Complete Spontaneous Bowel Movement (CSBM) Frequency Change From Baseline — 1.01; 1.50; 1.54; 1.57 number of bowel movements/week
Multiple Myeloma
Primary: Complete Response Rate — 7; 7 Participants
Gastroesophageal Reflux Disease
Primary: Percent Change From Baseline to Week 8 in Weekly Heartburn Severity Score (WHSS) — -46.026; -48.978; -55.063; -57.969 percentage change in score — p=0.6065